Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel ovomucoid-like pseudogene (ENSG00000283653) is a nonfunctional DNA sequence that resembles a functional gene but is incapable of producing a functional protein product[1][2][4]. Identified as a pseudogene, it likely arose from gene duplication or retrotransposition events and has lost its protein-coding potential through accumulated disabling mutations[2][4]. Pseudogenes generally have no direct protein-coding or biological function, but some can influence gene regulation through RNA-based mechanisms; however, no such function has been described for this particular pseudogene[1][4][6]. This entry does not correspond to an actionable or therapeutically relevant target. It is correctly cataloged as a pseudogene and therefore falls outside most drug discovery or translational research efforts focused on protein-coding targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel ovomucoid-like pseudogene.